However, the overall safety profile of taspoglutide was clearly worse than exenatide with respect to gastrointestinal tolerability, systemic allergic reactions, and injection-site reactions.
You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...
Medpage Today on MSN3d
FDA Adds New Warning to GLP-1 DrugsLabels of all GLP-1 receptor agonists now carry a warning about pulmonary aspiration during general anesthesia or deep ...
which was approved for SBS in adults in 2012 and children in 2019 – while AstraZeneca's GLP-1 drug Byetta/Bydureon (exenatide) has also been used off-label to treat the disorder. 9 Meters is ...
Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...
Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback